FR 173657
Alternative Names: FK 3657Latest Information Update: 10 Sep 2003
At a glance
- Originator Fujisawa
- Developer Fujisawa; Nonindustrial source
- Class Analgesics; Anti-inflammatories; Antiasthmatics
- Mechanism of Action Angiogenesis inhibitors; Bradykinin B2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Cancer; Ulcerative colitis